Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Diseases

Explore clinical trials studying Respiratory Tract Diseases. Study availability and eligibility vary by location and protocol.

37,354 public trials 4,963 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Diseases trial results

Recruiting

Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features

NCT06449313

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Lombardi Comprehensive Cancer Center, Georgetown University Washington D.C., District of Columbia, United States
  • Washington University School of Medicine-Sitemen Cancer Center St Louis, Missouri, United States
  • UVA Comprehensive Cancer Center Charlottesville, Virginia, United States
View Trial Details
Recruiting

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

NCT07444814

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
Locations
  • University of Arkansas Little Rock, Arkansas, United States
  • UCLA - Hematology/Oncology Clinical Research Unit Los Angeles, California, United States
  • St. Francis Medical Center (OSF Healthcare) Peoria, Illinois, United States
  • START - Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

NCT05176483

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +48 more
Locations
  • Exelixis Clinical Site #67 Phoenix, Arizona, United States
  • Exelixis Clinical Site #1 Tucson, Arizona, United States
  • Exelixis Clinical Site #123 Palo Alto, California, United States
  • Exelixis Clinical Site #59 Santa Barbara, California, United States
View all 122 locations
View Trial Details
Recruiting

Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

NCT06660355

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • Univ of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • University of Virginia Comprehensive Cancer Center Charlottesville, Virginia, United States
View Trial Details
Recruiting

AB122 Platform Study

NCT04999761

Conditions
Advanced or Metastatic Solid Tumor, Alveolar Soft Part Sarcoma, Biliary Tract Cancer, +41 more
Locations
  • A site selected by Taiho Pharmaceutical Co., Ltd. Aichi, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Chiba, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Ehime, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Hokkaido, Japan
View Trial Details
Recruiting

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

NCT06706076

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Hospital - Arizona Phoenix, Arizona, United States
  • The Regents of the University of California - Irvine, CA Campus Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
View all 42 locations
View Trial Details
Recruiting

IDOV-Immune for Advanced Solid Tumors

NCT06910657

Conditions
Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +94 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
  • Westmead Hospital Westmead, New South Wales, Australia
View Trial Details

Related conditions